CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-10 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −7,277 | $87.12 | $634K | 153,901 |
| 2025-06-10 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −7,310 | $88.29 | $645K | 146,591 |
| 2025-06-10 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −20,926 | $88.99 | $1.9M | 125,665 |
| 2025-06-10 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −15,825 | $89.85 | $1.4M | 109,840 |
| 2025-06-10 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −6,328 | $90.93 | $575K | 103,512 |
| 2025-06-10 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −100 | $91.66 | $9K | 103,412 |
| 2025-06-10 | Bonstein Sara Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −24,150 | 134,260 | ||
| 2025-06-10 | Bonstein Sara Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −23,740 | 35,610 |
Page 23 of 23 · 448 trades